Treatments for Moderate-to-Severe Acne Vulgaris: A Systematic Review and Network Meta-analysis
CONCLUSIONS: Based on this SLR/NMA, topical triple-agent FDC gel was the most efficacious and safe treatment for moderate-to-severe acne. J Drugs Dermatol. 2024;23(4): doi:10.36849/JDD.8148.PMID:38564399 | DOI:10.36849/JDD.8148 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: Julie C Harper Hilary Baldwin Saswata Paul Choudhury Deepti Rai Bikramaditya Ghosh Md Sohai Aman Abhra R Choudhury Sekhar Kumar Dutta Debalina Dey Subrata Bhattacharyya Tina Lin George Joseph Ankur A Dashputre Jerry K L Tan Source Type: research
Early and Sustained Acne Lesion Reductions With Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel
CONCLUSIONS: Lesion count reductions were significantly greater with CAB versus its dyads and vehicle gel as early as week 4, with substantial reductions observed after 12 weeks of treatment. This faster-acting and sustained efficacy of CAB gel—coupled with its optimized formulation, once-daily dosing, and tolerability—may positively impact treatment adherence. J Drugs Dermatol. 2024;23(3): doi:10.36849/JDD.7907.PMID:38443130 | DOI:10.36849/jdd.7907 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - March 5, 2024 Category: Dermatology Authors: Julie C Harper Leon H Kircik Michael Gold Adelaide A Hebert Jeffrey L Sugarman Lawrence Green Linda Stein Gold Hilary Baldwin Eric Guenin James Q DelRosso Source Type: research
